The influence of provider characteristics on resection rates and survival in patients with localized non-small cell lung cancer

Lung Cancer

Volumn 60, Issue 3, 2008, Pages 441-451

  Li, Wilson W L ^a   Visser, Otto ^b   Ubbink, Dirk T ^a   Klomp, Houke M ^c   Kloek, Jaap J ^a   de Mol, Bas A J M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Integraal Kankercentrum Amsterdam   (Netherlands)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Non small cell lung cancer; Patterns of care study; Provider characteristics; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DATA EXTRACTION; FEMALE; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; THORAX SURGERY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARDIOLOGY SERVICE, HOSPITAL; FEMALE; HOSPITALS; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; PROPORTIONAL HAZARDS MODELS;

EID: 44249088852     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.10.029     Document Type: Article

References (33)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Smythe W.R., and American College of Chest Physicians. Treatment of stage I non-small cell lung carcinoma. Chest 123 (2003) 181S-187S
3. Scott W.J., Howington J., Movsas B., and American College of Chest Physicians. Treatment of stage II non-small cell lung cancer. Chest 123 (2003) 188S-201S
4. Robinson L.A., Wagner Jr. H., Ruckdeschel J.C., and American College of Chest Physicians. Treatment of stage IIIA non-small cell lung cancer. Chest 123 (2003) 202S-220S
5. Manser R., Wright G., Hart D., Byrnes G., and Campbell D.A. Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev 1 (2005) CD004699
6. Grosclaude P., Galat J.P., Macé-Lesech J., Roumagnac-Machelard M., Mercier M., and Robillard J. Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France. Br J Cancer 72 (1995) 1278-1282
7. Damhuis R.A., and Schutte P.R. Resection rates and postoperative mortality in 7899 patients with lung cancer. Eur Respir J 9 (1996) 7-10
8. Fry W.A., Menck H.R., and Winchester D.P. The national cancer data base report on lung cancer. Cancer 77 (1996) 1947-1955
9. Laroche C., Wells F., Coulden R., Stewart S., Goddard M., Lowry E., et al. Improving surgical resection rate in lung cancer. Thorax 53 (1998) 445-449
10. Fry W.A., Phillips J.L., and Menck H.R. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer 86 (1999) 1867-1876
11. Gregor A., et al. Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax 56 (2001) 212-217
12. Cartman M.L., et al. Lung cancer: district active treatment rates affect survival. J Epidemiol Community Health 56 (2002) 424-429
13. Jack R.H., Gulliford M.C., Ferguson J., and Moller H. Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services?. Br J Cancer 88 (2003) 1025-1031
14. Little A.G., Rusch V.W., Bonner J.A., Gaspar L.E., Green M.R., Webb W.R., et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg 80 (2005) 2051-2056
15. Lathan C.S., Neville B.A., and Earle C.C. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol 24 (2006) 413-418
16. Martin-Ucar A.E., Waller D.A., Atkins J.L., Swinson D., O'Byrne K.J., and Peake M.D. The beneficial effects of specialist thoracic surgery on the resection rate for non-small-cell lung cancer. Lung Cancer 46 (2004) 227-232
17. Phillips A., and Lawrence G. Resection rates in lung cancer. Thorax 54 (1999) 374-375
18. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
19. van Meerbeeck J.P., Koning C.C., Tjan-Heijnen V.C., Boekema A.G., Kaandorp C.J., and Burgers J.S. Guideline on 'non-small cell lung carcinoma; staging and treatment'. Ned Tijdschr Geneeskd 149 (2005) 72-77
20. British Thoracic Society, and Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 56 (2001) 89-108
21. Beckles M.A., Spiro S.G., Colice G.L., Rudd R.M., and American College of Chest Physicians. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest 123 (2003) 105S-114S
22. Palmer M.J., O'Sullivan B., Steele R., and Mackillop W.J. Controversies in the management of non-small cell lung cancer: the results of an expert surrogate study. Radiother Oncol 19 (1990) 17-28
23. Raby B., Pater J., and Mackillop W.J. Does knowledge guide practice? Another look at the management of non-small-cell lung cancer. J Clin Oncol 13 (1995) 1904-1911
24. Perez E.A. Perceptions of prognosis, treatment, and treatment impact on prognosis in non-small cell lung cancer. Chest 114 (1998) 593-604
25. Schroen A.T., Detterbeck F.C., Crawford R., Rivera M.P., and Socinski M.A. Beliefs among pulmonologists and thoracic surgeons in the therapeutic approach to non-small cell lung cancer. Chest 118 (2000) 129-137
26. Warner C.D., Weintraub W.S., Craver J.M., Jones E.L., Gott J.P., and Guyton R.A. Effect of cardiac surgery patient characteristics on patient outcomes from 1981 through 1995. Circulation 96 (1997) 1575-1579
27. Greenberg E.R., Baron J.A., Dain B.J., Freeman Jr. D.H., Yates J.W., and Korson R. Cancer staging may have different meanings in academic and community hospitals. J Clin Epidemiol 44 (1991) 505-512
28. Bach P.B., Cramer L.D., Schrag D., Downey R.J., Gelfand S.E., and Begg C.B. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 345 (2001) 181-188
29. Jazieh A.R., Kyasa M.J., Sethuraman G., and Howington J. Disparities in surgical resection of early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg 123 (2002) 1173-1176
30. Janssen-Heijnen M.L., Smulders S., Lemmens V.E., Smeenk F.W., van Geffen H.J., and Coebergh J.W. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 59 (2004) 602-607
31. de Rijke J.M., Schouten L.J., ten Velde G.P., Wanders S.L., Bollen E.C., Lalisang R.I., et al. Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study. Lung Cancer 46 (2004) 233-245
32. Hillner B.E., Smith T.J., and Desch C.E. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol 18 (2000) 2327-2340
33. Birkmeyer J.D., Sun Y., Goldfaden A., Birkmeyer N.J., and Stukel T.A. Volume and process of care in high-risk cancer surgery. Cancer 106 (2006) 2476-2481